HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors

• Valeria Cento,

  Affiliation Department of Experimental Medicine and Biochemical Sciences, University of Tor Vergata, Rome, Italy

  ⨯
• Carmen Mirabelli,

  Affiliation Department of Experimental Medicine and Biochemical Sciences, University of Tor Vergata, Rome, Italy

  ⨯
• Romina Salpini,

  Affiliation Department of Experimental Medicine and Biochemical Sciences, University of Tor Vergata, Rome, Italy

  ⨯
• Salvatore Dimonte,

  Affiliation Department of Experimental Medicine and Biochemical Sciences, University of Tor Vergata, Rome, Italy

  ⨯
• Anna Artese,

  Affiliation Department of Pharmacobiological Sciences, University of Catanzaro “Magna Græcia”, Catanzaro, Italy

  ⨯
• Giosuè Costa,

  Affiliation Department of Pharmacobiological Sciences, University of Catanzaro “Magna Græcia”, Catanzaro, Italy

  ⨯
• Fabio Mercurio,

  Affiliation Department of Experimental Medicine and Biochemical Sciences, University of Tor Vergata, Rome, Italy

  ⨯
• Valentina Svicher,

  Affiliation Department of Experimental Medicine and Biochemical Sciences, University of Tor Vergata, Rome, Italy

  ⨯
• Lucia Parrotta,

  Affiliation Department of Pharmacobiological Sciences, University of Catanzaro “Magna Græcia”, Catanzaro, Italy

  ⨯
• Ada Bertoli,

  Affiliation Complex Unit of Molecular Virology, Tor Vergata University Hospital, Rome, Italy

  ⨯
• Marco Ciotti,

  Affiliation Complex Unit of Molecular Virology, Tor Vergata University Hospital, Rome, Italy

  ⨯
• Daniele Di Paolo,

  Affiliation Department of Internal Medicine, Tor Vergata University Hospital, Rome, Italy

  ⨯
• Cesare Sarrecchia,

  Affiliation Department of Public Health, Tor Vergata University Hospital, Rome, Italy

  ⨯
• Massimo Andreoni,

  Affiliation Department of Public Health, Tor Vergata University Hospital, Rome, Italy

  ⨯
• Stefano Alcaro,

  Affiliation Department of Pharmacobiological Sciences, University of Catanzaro “Magna Græcia”, Catanzaro, Italy

  ⨯
• Mario Angelico,

  Affiliation Department of Internal Medicine, Tor Vergata University Hospital, Rome, Italy

  ⨯
• Carlo Federico Perno,

  Affiliations Department of Experimental Medicine and Biochemical Sciences, University of Tor Vergata, Rome, Italy, Complex Unit of Molecular Virology, Tor Vergata University Hospital, Rome, Italy

  ⨯
•  [ ... ],
• Francesca Ceccherini-Silberstein

  * E-mail: ceccherini@med.uniroma2.it

  Affiliation Department of Experimental Medicine and Biochemical Sciences, University of Tor Vergata, Rome, Italy

  ⨯
• [ view all ]
• [ view less ]